Cargando…

Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer

Chemoresistance is the leading cause of poor prognosis in head and neck squamous cell carcinoma (HNSC); however, promising biomarkers to identify patients for stratified chemotherapy are lacking. Sideroflexin 3 (SFXN3) is an important mitochondrial serine transporter during one-carbon metabolism, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kailin, Gong, Sha, Fang, Xueliang, Li, Qian, Ye, Mingliang, Li, Junyan, Huang, Shengyan, Zhao, Yuheng, Liu, Na, Li, Yingqin, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493355/ https://www.ncbi.nlm.nih.gov/pubmed/36159813 http://dx.doi.org/10.3389/fimmu.2022.920136

Ejemplares similares

Comprehensive analysis of the role of SFXN family in breast cancer
por: Yuan, Ding, et al.
Publicado: (2023)

The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism
por: Acoba, Michelle Grace, et al.
Publicado: (2021)

The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo
por: Ledahawsky, Leire M., et al.
Publicado: (2022)

USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma
por: Chen, Yang, et al.
Publicado: (2022)

Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
por: Yagi, Kohei, et al.
Publicado: (2023)

A Prognostic Model of Head and Neck Cancer Based on Amino Acid Metabolism-Related Signature and Its Implication for Immunosuppressive Microenvironment
por: Li, Xuran, et al.
Publicado: (2023)

SFXN3 is Associated with Poor Clinical Outcomes and Sensitivity to the Hypomethylating Therapy in Non-M3 Acute Myeloid Leukemia Patients
por: Dong, Yuxuan, et al.
Publicado: (2023)

Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation
por: Chen, Ying, et al.
Publicado: (2022)

A High-Throughput Search for SFXN1 Physical Partners Led to the Identification of ATAD3, HSD10 and TIM50
por: Tifoun, Nesrine, et al.
Publicado: (2022)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
por: Luo, Ya, et al.
Publicado: (2020)

A gene expression-based immune content predictor for survival and postoperative radiotherapy response in head and neck cancer
por: Li, Yingqin, et al.
Publicado: (2021)

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
por: Jie, H-B, et al.
Publicado: (2013)

Immune Cells in Head-and-Neck Tumor Microenvironments
por: Jumaniyazova, Enar, et al.
Publicado: (2022)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy
por: Tu, Yaqin, et al.
Publicado: (2023)

Pyroptosis‐related gene signatures are associated with prognosis and tumor microenvironment infiltration in head and neck cancer
por: Long, Yan, et al.
Publicado: (2023)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Deregulation of purinergic ectoenzyme activity in head and neck cancer promotes immunosuppression
por: Marafon, Filomena, et al.
Publicado: (2022)

Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies
por: Gougousis, Spyridon, et al.
Publicado: (2022)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment
por: Nisar, Sabah, et al.
Publicado: (2021)

STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment
por: Anderson, Kelvin, et al.
Publicado: (2022)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
por: Xie, Qi-Hui, et al.
Publicado: (2022)

The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers
por: Xie, Changqing, et al.
Publicado: (2019)

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
por: Chevalier, Thomas, et al.
Publicado: (2021)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
por: de Medeiros, Marcell Costa, et al.
Publicado: (2022)

NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment
por: Chen, Xue-min, et al.
Publicado: (2022)

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Sukari, Ammar, et al.
Publicado: (2015)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
por: Li, Shasha, et al.
Publicado: (2023)

The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Chen, Fang, et al.
Publicado: (2022)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer
por: Shao, Baoyi, et al.
Publicado: (2023)

Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma
por: Chengcheng, Liu, et al.
Publicado: (2021)

The Unforeseen Non-Coding RNAs in Head and Neck Cancer
por: Irimie, Alexandra Iulia, et al.
Publicado: (2018)

Non-coding RNAs profiling in head and neck cancers
por: Salyakina, Daria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ne1hhosn8bh3bjbfjfhdm1r6r